smallcaptechnology.com
Telecom & Wireless Archives - Micro and Small Cap Technology Stocks
http://smallcaptechnology.com/category/news/telecom-wireless
Software & Hardware. Devices & Instruments. Telecom & Wireless. Micro and Small Cap Technology Stocks. Software & Hardware. Devices & Instruments. Telecom & Wireless. Otelco Inc. (OTT): Restructuring Transaction. February 1, 2013. Meru Networks (MERU): Fourth Quarter and Fiscal 2012 Financial Results. January 30, 2013. Powerwave (PWAV): Seeks Chapter 11 Bankruptcy Protection. January 28, 2013. Powerwave Technologies, Inc. (NASDAQ: PWAV) designs, manufactures, and markets end-to-end wireless solutions...
smallcapbiotech.com
Biotech News - Small Cap Biotechs
http://smallcapbiotech.com/category/news
SANUWAVE (SNWV): U.S. Patent to Sterilize Blood Using SNWV’s Shock Wave Technology. April 11, 2013. Comments Off on SANUWAVE (SNWV): U.S. Patent to Sterilize Blood Using SNWV’s Shock Wave Technology. BioCryst Pharmaceuticals (BCRX): Update Regarding Peramivir. April 1, 2013. Comments Off on BioCryst Pharmaceuticals (BCRX): Update Regarding Peramivir. Cell Therapeutics, Inc.(CTIC): $15MM Loan Financing Agreement. March 28, 2013. Cell Therapeutics, Inc. (CTIC) announced that it has entered into a Loan ...
smallcapbiotech.com
BioCryst Pharmaceuticals (BCRX): Update Regarding Peramivir - Small Cap Biotechs
http://smallcapbiotech.com/biocryst-pharmaceuticals-bcrx-update-regarding-peramivir
BioCryst Pharmaceuticals (BCRX): Update Regarding Peramivir. April 1, 2013. Comments Off on BioCryst Pharmaceuticals (BCRX): Update Regarding Peramivir. BioCryst Pharmaceuticals, Inc. ( NASDAQ:BCRX. Designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and inflammatory diseases. Jon P Stonehouse , President and Chief Executive Officer of BCRX, noted:. BioCryst’s current pipeline consists of the following development programs:. BCX4430 a broad spectrum an...
smallcapbiotech.com
Oncolytics Biotech (ONCY): Positive REOLSYIN Clinical Trial Data from Phase 2 Study
http://smallcapbiotech.com/oncolytics-biotech-oncy-positive-reolsyin-clinical-trial-data-from-phase-2-study
Oncolytics Biotech (ONCY): Positive REOLSYIN Clinical Trial Data from Phase 2 Study. February 8, 2013. Comments Off on Oncolytics Biotech (ONCY): Positive REOLSYIN Clinical Trial Data from Phase 2 Study. Oncolytics Biotech Inc. (NASDAQ: ONCY. Is focused on the development of oncolytic viruses for use as cancer therapeutics. The Company’s lead product, REOLYSIN. A proprietary formulation of the human reovirus, is currently in late stage (Phase III) clinical testing in head and neck cancers. REOLYSIN.
smallcapbiotech.com
AntriaBio (ANTB): An Opportunity - Small Cap Biotechs
http://smallcapbiotech.com/antriabio-antb-an-opportunity
AntriaBio (ANTB): An Opportunity. March 17, 2013. Comments Off on AntriaBio (ANTB): An Opportunity. Novo Nordisk – the world’s largest insulin producer – and major diabetes drug manufacturers – could see BILLIONS in recurring revenue dry up as a small, California-based biotech company advances a technology that promises to change diabetes treatment. The Company that’s making executives in the world’s largest pharmaceutical firms sweat is Menlo Park, California-based ANTRIABIO, INC. ( ANTB. Antriabio̵...
smallcapbiotech.com
Imprimis Pharmaceuticals (IMMY): Pricing of Public Offering at $5.25 per Share
http://smallcapbiotech.com/imprimis-pharmaceuticals-immy-pricing-of-public-offering-at-5-25-per-share
Imprimis Pharmaceuticals (IMMY): Pricing of Public Offering at $5.25 per Share. February 8, 2013. Comments Off on Imprimis Pharmaceuticals (IMMY): Pricing of Public Offering at $5.25 per Share. Imprimis Pharmaceuticals, Inc. ( IMMY. Imprimis completed a 1-for-5 reverse stock split on February 7, 2013 and its common shares traded on The NASDAQ Capital Market under the ticker symbol IMMY. OXiGENE (OXGN): ZYBRESTAT Plus Avastin Well Tolerated in Second Interim Toxicity Analysis of a Phase 2 Trial. Hereditar...
microcapenergy.com
News Archives - Micro Cap Energy
http://microcapenergy.com/category/news
News Archives - Micro Cap Energy. Oil & Gas. Oil & Gas. Synthesis Energy Systems (SYMX): Jointly Market SES Gasification and GE Aeroderivative Gas Turbine Technologies with GE. April 2, 2013. Active Power (ACPW): Appoints Thomas Patrick Kelly to Board of Directors. January 26, 2013. Cleantech Solutions International (CLNT): $3.2MM in Two Purchase Orders. January 7, 2013. Cleantech Solutions International (CLNT) operates two manufacturing affiliates the Huayang Companies in Wuxi China. Using precision...
microcapenergy.com
Oil & Gas Archives - Micro Cap Energy
http://microcapenergy.com/category/oil-gas
Oil and Gas Archives - Micro Cap Energy. Oil & Gas. Oil & Gas. Synthesis Energy Systems (SYMX): Jointly Market SES Gasification and GE Aeroderivative Gas Turbine Technologies with GE. April 2, 2013. Zion Oil and Gas (ZN): Drops Exploration at the Elijah #3 Well. January 25, 2013. Oil Caps: Weekly Best Performer in Three Months Period. January 5, 2013. Oil gained in New York, capping the biggest weekly advance in three months, after U.S. employers hired more workers than expected in December. ...US Energy...
microcapenergy.com
Electric Utilities Archives - Micro Cap Energy
http://microcapenergy.com/category/utilities/electric-utilities
Electric Utilities Archives - Micro Cap Energy. Oil & Gas. Oil & Gas. Synthesis Energy Systems (SYMX): Jointly Market SES Gasification and GE Aeroderivative Gas Turbine Technologies with GE. April 2, 2013. Active Power (ACPW): Appoints Thomas Patrick Kelly to Board of Directors. January 26, 2013. Synthesis Energy Systems (SYMX): Jointly Market SES Gasification and GE Aeroderivative Gas Turbine Technologies with GE. ZBB Energy Corporation (ZBB): NewSite in Southern California. Oil & Gas. Info at microcape...
SOCIAL ENGAGEMENT